Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models
- PMID: 22574684
- DOI: 10.3109/10408444.2012.680431
Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models
Abstract
The etiology of Parkinson's disease (PD) is attributed to both environmental and genetic factors. The development of PD reportedly involves mitochondrial impairment, oxidative stress, α-synuclein aggregation, dysfunctional protein degradation, glutamate toxicity, calcium overloading, inflammation and loss of neurotrophic factors. Based on a link between mitochondrial dysfunction and pesticide exposure, many laboratories, including ours, have recently developed parkinsonian models by utilization of rotenone, a well-known mitochondrial complex I inhibitor. Rotenone models for PD appear to mimic most clinical features of idiopathic PD and recapitulate the slow and progressive loss of dopaminergic (DA) neurons and the Lewy body formation in the nigral-striatal system. Notably, potential human parkinsonian pathogenetic and pathophysiological mechanisms have been revealed through these models. In this review, we summarized various rotenone-based models for PD and discussed the implied etiology of and treatment for PD.
Similar articles
-
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.J Neurosci Res. 2010 Feb 1;88(2):420-7. doi: 10.1002/jnr.22201. J Neurosci Res. 2010. PMID: 19681169
-
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.Ann Neurol. 2014 Mar;75(3):351-62. doi: 10.1002/ana.24066. Epub 2014 Feb 18. Ann Neurol. 2014. PMID: 24243558
-
Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.Neurochem Int. 2009 Dec;55(8):760-7. doi: 10.1016/j.neuint.2009.07.009. Epub 2009 Aug 6. Neurochem Int. 2009. PMID: 19647776
-
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Free Radic Biol Med. 2013. PMID: 23743292 Review.
-
Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.Biofactors. 2011 May-Jun;37(3):228-40. doi: 10.1002/biof.159. Epub 2011 Jun 14. Biofactors. 2011. PMID: 21674642 Review.
Cited by
-
Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism.Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10756-10761. doi: 10.1073/pnas.1808945115. Epub 2018 Sep 10. Proc Natl Acad Sci U S A. 2018. PMID: 30201710 Free PMC article.
-
Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice.J Mol Neurosci. 2020 Jan;70(1):102-111. doi: 10.1007/s12031-019-01405-w. Epub 2019 Sep 13. J Mol Neurosci. 2020. PMID: 31520365 Free PMC article.
-
4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation.Neurochem Res. 2022 Nov;47(11):3385-3401. doi: 10.1007/s11064-022-03691-0. Epub 2022 Aug 3. Neurochem Res. 2022. PMID: 35922743
-
Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.PLoS One. 2023 Nov 16;18(11):e0294612. doi: 10.1371/journal.pone.0294612. eCollection 2023. PLoS One. 2023. PMID: 37972114 Free PMC article.
-
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation.Mucosal Immunol. 2018 Jan;11(1):120-130. doi: 10.1038/mi.2017.31. Epub 2017 Apr 12. Mucosal Immunol. 2018. PMID: 28401939 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
